论文部分内容阅读
目的分析米非司酮联合米索前列醇终止高危妊娠的临床有效性。方法选取我院2014年2月~2015年2月收治的高危妊娠180例,并且根据不同的治疗方式分为人工组和联合组,各90例,人工组高危妊娠患者采取人工流产手术,联合组患者采取米非司酮联合米索前列醇,比较两组患者终止妊娠的有效性。结果联合组患者妊娠终止有效率为95.56%,并发症发生率为12.22%;人工组妊娠终止有效率为82.22%,并发症发生率为26.67%,联合组组患者妊娠终止有效率和并发症的发生率均优于人工组,差异有统计学意义(P<0.05)。结论对于终止高危妊娠,米非司酮联合米索前列醇给药治疗具有显著的疗效,不但能够减轻手术对患者的损伤,还能有效降低患者发生并发症的几率,应用价值较高。
Objective To analyze the clinical efficacy of mifepristone combined with misoprostol to terminate high-risk pregnancy. Methods 180 cases of high-risk pregnancy admitted to our hospital from February 2014 to February 2015 were selected and divided into two groups according to different treatment methods: 90 cases in each group and 90 cases in high-risk pregnancy group. Artificial abortion was performed in the joint group Patients taking mifepristone combined with misoprostol compared the effectiveness of termination of pregnancy in both groups. Results The effective rate of termination of pregnancy in the combined group was 95.56%, the incidence of complications was 12.22%. The effective rate of termination of pregnancy in artificial group was 82.22%, the incidence of complications was 26.67%. The effective rate of termination of pregnancy and complication The incidence was better than that of artificial group, the difference was statistically significant (P <0.05). Conclusion For the termination of high-risk pregnancy, mifepristone combined with misoprostol administration has a significant effect, not only can reduce the operation of patients with injury, but also reduce the incidence of complications in patients with a high probability.